Close

Recro Pharma (REPH) Reports Q2 Loss of $0.83/Share

Go back to Recro Pharma (REPH) Reports Q2 Loss of $0.83/Share
RECRO PHARMA (NASDAQ: REPH) Delayed: 2.09 --0 (-0%)
Previous Close $2.09    52 Week High $12.50 
Open $2.09    52 Week Low $5.59 
Day High $2.09    P/E N/A 
Day Low $2.09    EPS $0.00 
Volume 528,065